GC tissues; adjacent normal tissue; serum; tumor tissues
GES-1; MKN-45; MKN45; AGS; SNU-5; THP-1
cell line-derived xenograft
ceRNA regulation (other); apoptosis (promotes); proliferation (inhibits); migration (inhibits); invasion (inhibits); EMT (inhibits); macrophage polarization (inhibits); immune regulation (other); JAK/STAT (inhibits)
RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis; Luciferase Reporter Assay; FISH / smFISH; RNA Pull-Down; Transfection; CCK8; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot; Flow Cytometry(Non-apoptosis/cycle); IF (Immunofluorescence); ELISA; In Vivo Animal Model; H&E Staining; IHC (Immunohistochemistry)
hsa_circ_0017252 was significantly downregulated in GC tissues and serum of patients with GC, suggesting potential relevance to GC diagnosis or treatment development, but no formal diagnostic or prognostic analysis was reported.
hsa_circ_0017252 is downregulated in GC tissues, serum, and GC cells. It suppresses GC malignancy by sponging miR-17-5p, upregulating DUSP2, reducing p-STAT3 signaling, inhibiting macrophage M2-like polarization, and thereby decreasing GC cell migration, invasion, EMT-like changes, and tumor growth while promoting apoptosis.
0.7761
Exosomal hsa_circ_0017252 attenuates the development of gastric cancer via inhibiting macrophage M2 polarization.
combined biological and clinical study